NCT00054327View on ClinicalTrials.gov

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
LeukemiaLymphomaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Interventions
DRUG

busulfan

Given orally 1mg/kg/dose (or 40mg/m2/dose for young children)

DRUG

cyclophosphamide

Given IV

DRUG

cytarabine

Given IV

RADIATION

radiation therapy

Patients undergo total body irradiation

DRUG

Etoposide

infusion

PROCEDURE

Stem Cell Transfusion

Trial Locations (1)

44106-5065

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00054327 - Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter